These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 10334688

  • 1. Oral desensitization in patients with chronic tophaceous gout and allopurinol hypersensitivity.
    Gillott TJ, Whallett A, Zaphiropoulos G.
    Rheumatology (Oxford); 1999 Jan; 38(1):85-6. PubMed ID: 10334688
    [No Abstract] [Full Text] [Related]

  • 2. Allopurinol sensitivity in a patient with chronic tophaceous gout: success of intravenous desensitization after failure of oral desensitization.
    Walz-LeBlanc BA, Reynolds WJ, MacFadden DK.
    Arthritis Rheum; 1991 Oct; 34(10):1329-31. PubMed ID: 1930322
    [Abstract] [Full Text] [Related]

  • 3. Successful desensitisation of allopurinol-induced erythema multiforme.
    Fonseka MM, Sathischandra H, Jayamanne SF, de Silva HJ.
    Ceylon Med J; 1999 Dec; 44(4):190-1. PubMed ID: 10895280
    [No Abstract] [Full Text] [Related]

  • 4. Desensitization to allopurinol in a patient with previous failed desensitization.
    Tanna SB, Barnes JF, Seth SK.
    Ann Pharmacother; 1999 Nov; 33(11):1180-3. PubMed ID: 10573316
    [Abstract] [Full Text] [Related]

  • 5. How should we treat tophaceous gout in patients with allopurinol hypersensitivity?
    Grahame R, Simmonds HA, McBride MB, Marsh FP.
    Adv Exp Med Biol; 1998 Nov; 431():19-23. PubMed ID: 9598024
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Desensitisation in a patient with chronic renal disease and severe allergy to allopurinol.
    Meyrier A.
    Br Med J; 1976 Aug 21; 2(6033):458. PubMed ID: 953607
    [No Abstract] [Full Text] [Related]

  • 10. How should hyperuricemia be treated in a patient with allopurinol hypersensitivity?
    Monev SD.
    Cleve Clin J Med; 2001 Jul 21; 68(7):597-8. PubMed ID: 11453075
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Familial hypersensitivity to allopurinol with subsequent desensitization.
    Melsom RD.
    Rheumatology (Oxford); 1999 Dec 21; 38(12):1301. PubMed ID: 10587570
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Fatal outcome in allopurinol hypersensitivity syndrome].
    Kluger E.
    Ugeskr Laeger; 1998 Feb 16; 160(8):1179-80. PubMed ID: 9492630
    [Abstract] [Full Text] [Related]

  • 20. Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.
    Fam AG.
    Curr Rheumatol Rep; 2001 Feb 16; 3(1):29-35. PubMed ID: 11177768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.